AiM Medical Robotics reposted this
Hope you’re ready to binge-watch a marathon of milestones because the LSI Alumni are back with 15 new milestones 🍿 This week the #LSIAlumni closed new funding rounds, granted FDA clearance, launched new products, and much more on the road to #LSIEurope24. Your 60-second news recap: Access Vascular, Inc. — James Biggins → Presented new data demonstrating that its MIMIX® hydrophilic biomaterial significantly reduces bacterial adhesion and thrombus accumulation in their catheters compared with conventional catheters. AiM Medical Robotics — Gregory Fischer → Announced a partnership with Brigham and Women's Hospital for the First Human Clinical Study for MRI-guided Device Placement in the Brain. → Additionally announced a collaboration with LSI Alumni, Synaptive Medical to integrate the Modus Nav neuro-navigation software with AiM's robot, which is also demonstrated in this trial. Brainomix — Michalis Papadakis → Announced the FDA clearance of its latest product, Brainomix 360 e-Lung. CorTec — Dr. Oliver Baertl → Granted FDA IDE approval for an Early Feasibility Study using CorTec’s Closed-Loop Brain Interchange implant system. Deep Blue Medical Advances, Inc. — Bill Perry → Received the Luis Villalobos Award from Angel Capital Association as Innovative Life Science Company of 2024. Egg Medical — Robert Wilson → Partnered with Levant to bring its EggNest Radiation Protection System to Israel. OUI Medical Inc — Dr Adarsh M Patil → Granted a utility patent for its P-scope device. The device is a disposable, portable handheld scope that includes an integrated camera, screen, processor, battery, and biopsy forceps. Oxford Endovascular Ltd. — Mike Karim → Raised £8M in a Series A funding round led by Parkwalk Advisors. Pristine Surgical — Bryan Lord, David Carey → Announced the addition of Christopher Cleary to its Board of Directors. S2N Health — Amy Siegel, Haley Woloshen → Closed a Seed funding round led by Excelerate Health Ventures. → Expanded its Board of Directors by adding seasoned Medtech entrepreneur and executive Martha Shadan who has more than three decades of experience in the life science industry. Shoulder Innovations — Rob Ball → Launched its latest product, the InSet™ 95 Humeral Stem designed to enhance surgical outcomes and improve patient recovery for those suffering from poor bone quality. Valcare Medical — Steve Sandweg → Announced enrollment of the first two patients in AMEND™ TS European pilot study. Vessl Prosthetics — Sydney Robinson → Announced the appointment of Tres Wright as its Go To Market and Sales Advisor. Volta Medical — Théophile Mohr Durdez → Announced positive results from its FDA IDE trial, Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation. XEOS → Announced that Vincent Keereman, Co-Founder and CMO, has been appointed to CEO. Congratulations to all the LSI Alumni who made major news this week!
Steve Sandweg
3mo
Appreciate the recognition from the LSI Team with todays post! I am pleased to report Valcare successfully treated its 3rd patient this week in the AMEND TS EU Pilot Study. More to soon follow👍
Thank You LSI for the shout out this this a majour win for us .
Bill Perry
3mo
Thank you LSI for including Deep Blue Medical and our award win! Grateful for you partnership and for the team win!
Bryan Lord
3mo
Thanks for the shoutout, LSI!
David Carey
3mo
Thank you LSI for the shoutout!
Sydney Robinson
3mo
Thank you LSI! We are so thrilled to have Tres Wright on board!
Vincent Keereman
3mo
Thanks LSI for the shoutout!
Thanks LSI for the shoutout! Quite a month for S2N!